Delivery Order SPE2DB20D1100-SPE2DB25FE0RY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,961.57 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this contract. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12,436.60 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Entresto 24 mg-26 mg tablets (180 count). This competitive, firm fixed-price contract involves no set-aside designation and requires delivery by September 11, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,209.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count packaging). The contract, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and runs through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,979.12 on September 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $8,660.44 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count packaging) under a firm fixed price contract. This competitive award, effective September 11, 2025, with an ultimate completion date of September 12, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,295.96 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This firm fixed-price delivery order is non-competitive and will be completed by August 11, 2025, with performance originating from AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $7,948.17 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Entresto 97 mg-103 mg on September 26, 2025, with completion targeted for September 29, 2025. This competitively awarded, firm fixed-price order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $28,607.13 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180 count) on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,903.32 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (60-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,618.73 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price, competitively awarded delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0RYDelivery Order
The Defense Logistics Agency awarded a $11,418.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside award was competitively procured and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract awards with the Defense Logistics Agency and Medical Supply Chain demonstrate its capability to fulfill diverse pharmaceutical requirements for defense and veteran healthcare systems. This specific delivery order for Entresto, a cardiovascular medication, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles that enable responsive medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/22/25 |